These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Agmatine protects against intracerebroventricular streptozotocin-induced water maze memory deficit, hippocampal apoptosis and Akt/GSK3β signaling disruption. Moosavi M; Zarifkar AH; Farbood Y; Dianat M; Sarkaki A; Ghasemi R Eur J Pharmacol; 2014 Aug; 736():107-14. PubMed ID: 24769303 [TBL] [Abstract][Full Text] [Related]
44. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells. Ghosh JC; Altieri DC Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644 [TBL] [Abstract][Full Text] [Related]
45. Role of the Akt/GSK-3β/CRMP-2 pathway in axon degeneration of dopaminergic neurons resulting from MPP+ toxicity. Fang W; Gao G; Zhao H; Xia Y; Guo X; Li N; Li Y; Yang Y; Chen L; Wang Q; Li L Brain Res; 2015 Mar; 1602():9-19. PubMed ID: 25150591 [TBL] [Abstract][Full Text] [Related]
46. Phosphorylation of glycogen synthase kinase-3 beta at serine 9 confers cisplatin resistance in ovarian cancer cells. Cai G; Wang J; Xin X; Ke Z; Luo J Int J Oncol; 2007 Sep; 31(3):657-62. PubMed ID: 17671694 [TBL] [Abstract][Full Text] [Related]
47. Neuronal polarity is regulated by glycogen synthase kinase-3 (GSK-3beta) independently of Akt/PKB serine phosphorylation. Gärtner A; Huang X; Hall A J Cell Sci; 2006 Oct; 119(Pt 19):3927-34. PubMed ID: 16954147 [TBL] [Abstract][Full Text] [Related]
48. Involvement of the Akt/GSK-3β/CRMP-2 pathway in axonal injury after hypoxic-ischemic brain damage in neonatal rat. Xiong T; Tang J; Zhao J; Chen H; Zhao F; Li J; Qu Y; Ferriero D; Mu D Neuroscience; 2012 Aug; 216():123-32. PubMed ID: 22554777 [TBL] [Abstract][Full Text] [Related]
49. Glycogen synthase kinase-3beta (GSK3beta) binds to and promotes the actions of p53. Watcharasit P; Bijur GN; Song L; Zhu J; Chen X; Jope RS J Biol Chem; 2003 Dec; 278(49):48872-9. PubMed ID: 14523002 [TBL] [Abstract][Full Text] [Related]
51. GSK3β expression and phosphorylation during neuronal maturation in the rat dorsal root ganglion. Tang W; Han N; Liu Y; Li Z; Wei Y Int J Clin Exp Med; 2015; 8(4):5897-903. PubMed ID: 26131182 [TBL] [Abstract][Full Text] [Related]
52. Identification and analysis of glycogen synthase kinase 3 beta1 interactome. Gao X; Wang JY; Gao LM; Yin XF; Liu L Cell Biol Int; 2013 Aug; 37(8):768-79. PubMed ID: 23505128 [TBL] [Abstract][Full Text] [Related]
53. Structure and mechanism of the unique C2 domain of Aida. Zheng LS; Liu YT; Chen L; Wang Y; Rui YN; Huang HZ; Lin SY; Wang J; Wang ZX; Lin SC; Wu JW FEBS J; 2014 Oct; 281(20):4622-32. PubMed ID: 25117763 [TBL] [Abstract][Full Text] [Related]
54. Mapping functional interaction sites of human prune C-terminal domain by NMR spectroscopy in human cell lysates. Diana D; Smaldone G; De Antonellis P; Pirone L; Carotenuto M; Alonzi A; Di Gaetano S; Zollo M; Pedone EM; Fattorusso R Chemistry; 2013 Sep; 19(37):12217-20. PubMed ID: 23939913 [TBL] [Abstract][Full Text] [Related]
55. Prediction of the binding mode between GSK3β and a peptide derived from GSKIP using molecular dynamics simulation. Tang XN; Lo CW; Chuang YC; Chen CT; Sun YC; Hong YR; Yang CN Biopolymers; 2011 Jul; 95(7):461-71. PubMed ID: 21328310 [TBL] [Abstract][Full Text] [Related]
56. Calpain inhibitors: The aspirin of the 21st century? Crestanello JA J Thorac Cardiovasc Surg; 2017 Feb; 153(2):358-359. PubMed ID: 27865555 [No Abstract] [Full Text] [Related]
58. Challenges of studying 14-3-3 protein-protein interactions with full-length protein partners. Somsen BA; Ottmann C Biophys J; 2022 Apr; 121(7):1115-1116. PubMed ID: 35320703 [No Abstract] [Full Text] [Related]
59. A possible mechanism to the antidepressant-like effects of 20 (S)-protopanaxadiol based on its target protein 14-3-3 ζ. Chen L; Li R; Chen F; Zhang H; Zhu Z; Xu S; Cheng Y; Zhao Y J Ginseng Res; 2022 Sep; 46(5):666-674. PubMed ID: 36090685 [TBL] [Abstract][Full Text] [Related]
60. When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's Disease. D'Mello SR Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072862 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]